Drug intelligence / Profile preview

magnesium salicylate

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Magnesium salicylate is a nonsteroidal anti-inflammatory drug (NSAID) and analgesic used for the symptomatic relief of mild to moderate pain. It is commonly used to treat musculoskeletal pain such as backache and arthritis. As an NSAID in the salicylates class (related to aspirin), it works by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis—thereby reducing inflammation and pain. Magnesium salicylate is available over-the-counter in several formulations and brand names[1][2][3][4][5][6][8].

Brand names: DoansDoan's PillsMSTMobidinMaganDiurexMasalateNovasalPercogesic Backache ReliefLorisalAnalateTriact
Other names: magnesium salicylate tetrahydrate

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on magnesium salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium salicylate.

Explore the full profile